News

Barclays Flags Medtronic, J&J as Most at Risk from Looming Pharma Tariffs
Barclays outlines which MedTech stocks could feel the most pressure from Trump's anticipated global pharmaceutical tariffs ...
Barclays names most and least affected healthcare companies from tariffs
Barclays, in a report, says that Abbott (NYSE:ABT) and Baxter (NYSE:BAX) will be among least affected, while Johnson & ...
Inflation Report Helps Buoy Markets
Equities in Canada enjoyed a banner day Tuesday, as encouraging inflation numbers worked their way into the mix. Easing tariff news from the Trump White House also proved a factor. The TSX Composite ...
3 of Wall Street’s Favorite Stocks in the Doghouse
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, ...
Stifel Nicolaus Sticks to Their Buy Rating for Glaukos (GKOS)
Stifel Nicolaus analyst Thomas Stephan maintained a Buy rating on Glaukos (GKOS – Research Report) today and set a price target of $140.00.Stay ...